Top Japanese pharma companies join forces for global R&D project

A new $100m pioneering partnership has been set up between five of Japan’s largest pharma companies, the Bill & Melinda Gates Foundation and the Japanese government, with the aim of funding international research into neglected tropical diseases that affect the poor.

The first project funded by this new partnership will allow scientists to have access to five Japanese pharma companies’ compound libraries in order to search for new drug candidates in the areas of HIV, malaria and tuberculosis, among others.

The five companies involved are Astellas, Eisai, Daiichi Sankyo, Shionogi and Takeda, who have all agreed to join forces, each pledging $1 million over five years.

This project is a turnaround for Japanese pharma, who have been slower than their Western counterparts to invest in emerging markets.

 

 

Related news:

Japanese drugmakers open ‘libraries’ in $100 million health project (Reuters)

Japan in pioneering partnership to fund global health research (Financial Times)

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.